FDA Commissioner Von Eschenbach Makes Resignation Plans Official
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach will resign from the agency Jan. 20, which means the Obama administration needs to have an interim replacement ready to go on Inauguration Day
You may also be interested in...
GOP Lawmakers Signal FDA Won’t Escape Congressional Crosshairs In 2009
FDA remains in the crosshairs of congressional investigators, and given that Republicans are doing some of the gunning, the agency should expect continued barrages even after the change in administrations
FDA's Schwetz Is Acting Commissioner: Is RU-486 New Touchstone?
Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of FDA Commissioner Jane Henney, MD.
Bridge Too Far? BMS Launch Plan For Sotyktu Pressured By Prospect Of Medicare Price Controls
With price controls in Medicare looming nine years after approval, launch strategies such as ‘bridge’ programs that build initial volume with free drug may have to be adjusted.